GMED
Globus Medical, Inc.
Platform & Compounding FCF
B-
68.5 / 100 composite
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
-
5yr Avg ROIC
8.1%
-
Operating Margin Trend
-1.89 pp/yr
-
5yr Avg ROE
7.2%
-
5yr Share-Count CAGR
6.3%
-
5yr Revenue CAGR
30.1%
-
5yr EPS CAGR
31.2%
-
Revenue-Growth Years (5)
5/5
-
5yr FCF Margin
16.0%
-
5yr FCF/NI Conversion
1.68x
-
Net Debt / EBITDA
-0.60x
-
Interest Coverage (EBIT/Int)
30.00x
-
Altman Z-Score
10.33
Stability
Weight: 5%
B-
62
-
EPS Volatility (σ/μ)
0.58
-
Negative-Revenue Years (5)
0/5
-
Piotroski F-Score
8
3 of 3 gurus held; 2 added; 1 trimmed.
- Holders
- 3
- Avg Δ position
-
+8.5%
- New buys
- 0
- Full exits
- 0